Tsai YC - Search Results

1

Genetic variants in MAPK10 modify renal cell carcinoma susceptibility and clinical outcomes.

Tsai YC, Huang CY, Hsueh YM, Fan YC, Fong YC, Huang SP, Geng JH, Chen LC, Lu TL, Bao BY. Tsai YC, et al. Life Sci. 2021 Jun 15;275:119396. doi: 10.1016/j.lfs.2021.119396. Epub 2021 Mar 24. Life Sci. 2021. PMID: 33774030

2

Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic Thyroid Cancer.

Chen MC, Tsai YC, Tseng JH, Liou JJ, Horng S, Wen HC, Fan YC, Zhong WB, Hsu SP. Chen MC, et al. Among authors: tsai yc. Int J Mol Sci. 2017 Dec 13;18(12):2690. doi: 10.3390/ijms18122690. Int J Mol Sci. 2017. PMID: 29236027 Free PMC article.

3

A Synergistic Anti-Cancer Effect of Troglitazone and Lovastatin in a Human Anaplastic Thyroid Cancer Cell Line and in a Mouse Xenograft Model.

Zhong WB, Tsai YC, Chin LH, Tseng JH, Tang LW, Horng S, Fan YC, Hsu SP. Zhong WB, et al. Among authors: tsai yc. Int J Mol Sci. 2018 Jun 22;19(7):1834. doi: 10.3390/ijms19071834. Int J Mol Sci. 2018. PMID: 29932104 Free PMC article.

4

Tumor-infiltrating Leukocytes Suppress Local Inflammation Via Interleukin-1 Receptor Antagonist in a Syngeneic Prostate Cancer Model.

Fan YC, Chen WY, Lee KD, Tsai YC. Fan YC, et al. Among authors: tsai yc. Biology (Basel). 2020 Mar 31;9(4):67. doi: 10.3390/biology9040067. Biology (Basel). 2020. PMID: 32244522 Free PMC article.

5

Roles of Interleukin-1 Receptor Antagonist in Prostate Cancer Progression.

Fan YC, Lee KD, Tsai YC. Fan YC, et al. Among authors: tsai yc. Biomedicines. 2020 Dec 13;8(12):602. doi: 10.3390/biomedicines8120602. Biomedicines. 2020. PMID: 33322099 Free PMC article.

6

Investigation of Anti-Tumor Effects of an MLK1 Inhibitor in Prostate and Pancreatic Cancers.

Fan YC, Hsu KC, Lin TE, Zechner D, Hsu SP, Tsai YC. Fan YC, et al. Among authors: tsai yc. Biology (Basel). 2021 Aug 2;10(8):742. doi: 10.3390/biology10080742. Biology (Basel). 2021. PMID: 34439974 Free PMC article.

7

Disruption of CCL2 in Mesenchymal Stem Cells as an Anti-Tumor Approach against Prostate Cancer.

Bui QT, Lee KD, Fan YC, Lewis BS, Deng LW, Tsai YC. Bui QT, et al. Among authors: tsai yc. Cancers (Basel). 2023 Jan 10;15(2):441. doi: 10.3390/cancers15020441. Cancers (Basel). 2023. PMID: 36672395 Free PMC article.

8

Tumor-derived interleukin-1 receptor antagonist exhibits immunosuppressive functions and promotes pancreatic cancer.

Fan YC, Fong YC, Kuo CT, Li CW, Chen WY, Lin JD, Bürtin F, Linnebacher M, Bui QT, Lee KD, Tsai YC. Fan YC, et al. Among authors: tsai yc. Cell Biosci. 2023 Aug 10;13(1):147. doi: 10.1186/s13578-023-01090-8. Cell Biosci. 2023. PMID: 37563620 Free PMC article.

9

Identifying the role of MTHFD1L in prostate cancer progression from genetic analysis and experimental validation.

Tsai YC, Huang SP, Cheng WC, Fan YC, Lin YC, Tsai SY, Huang CY, Yu CC, Lin VC, Geng JH, Li CY, Lu TL, Bao BY. Tsai YC, et al. Among authors: tsai sy. Am J Cancer Res. 2024 Jan 15;14(1):169-181. doi: 10.62347/ASMT9261. eCollection 2024. Am J Cancer Res. 2024. PMID: 38323273 Free PMC article.

10

Epidermal growth factor receptor signaling promotes metastatic prostate cancer through microRNA-96-mediated downregulation of the tumor suppressor ETV6.

Tsai YC, Chen WY, Siu MK, Tsai HY, Yin JJ, Huang J, Liu YN. Tsai YC, et al. Among authors: tsai hy. Cancer Lett. 2017 Jan 1;384:1-8. doi: 10.1016/j.canlet.2016.10.014. Epub 2016 Oct 13. Cancer Lett. 2017. PMID: 27746161

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,608 results

Search Page

Filters